Drugs & Pharmaceuticals

Ask any chronic pain patient about gabapentin (Neurontin) as a replacement for opioids and you'll probably get one of two reactions: Laughter or tears.

I want to discuss the idea of superiority trials for antibiotics and some of the issues that many experienced researchers fail to consider when thinking about this topic. I am grateful to George Drusano for his input here. 

There is an urgent need for research in the area of pain management. Since the 1890s, when aspirin and heroin were discovered, there has been agonizingly little progress in this field.

Melatonin has been in the news recently because of potential safety concerns in children,

Recent demands by mainstream transgender communities insist on Americans conforming to respecting the words people use to describe themselves, including during physician visits and hospital admissions.

An article in The People's Daily Online, China's largest newspaper, reports that Azvudine (aka FNC), a reverse transcriptase inhibitor (1)  – is be

You probably know the old joke: What is the difference between God and doctors? God doesn't play doctor.

Paxlovid, the most widely prescribed drug to treat symptomatic COVID-19, has lately attracted a number of detractors.

The FDA just made it easier for people who have Covid to get their hands on Pfizer's antiviral drug Paxlovid, the standard of care for treating the infection.

An important drug from a giant drug company is bound to have a target on its back. Lately, this has been the case with Pfizer's Paxlovid.